Showing results (1331-1340 of 1,887) with videos related to
Sort By:
Pageof 189
The British Journal of Dermatology|March 4, 2020
Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Z Z N Yiu, K J Mason, P J Hampton, et al.The Journal of Investigative Dermatology|February 8, 2008
Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasisRichard B Warren, Rhodri L L Smith, Emanuela Campalani, et al.Cells|September 8, 2023
Human Mast Cells Upregulate Cathepsin B, a Novel Marker of Itch in PsoriasisPeter W West, Chiara Tontini, Haris Atmoko, et al.Journal of Pediatric Gastroenterology and Nutrition|May 27, 2024
Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long-term extension resultsDan Turner, Joel R Rosh, Stanley A Cohen, et al.The Journal of Clinical Investigation|November 12, 2019
Loss of ARPC1B impairs cytotoxic T lymphocyte maintenance and cytolytic activityLyra O Randzavola, Katharina Strege, Marie Juzans, et al.International Journal of Cosmetic Science|January 21, 2019
Mass spectrometry-based proteomics reveals the distinct nature of the skin proteomes of photoaged compared to intrinsically aged skinV L Newton, I Riba-Garcia, C E M Griffiths, et al.JAMA Dermatology|December 2, 2020
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study From the British Association of Dermatologists Biologics and Immunomodulators RegisterZenas Z N Yiu, Kayleigh J Mason, Philip J Hampton, et al.The British Journal of Dermatology|April 29, 2021
Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy studyA B Gottlieb, J F Merola, K Reich, et al.Human Immunology|September 15, 1996
Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in miceM A Gonzalez-Gay, E Zanelli, S D Khare, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1994
Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an Ek alpha transgeneM M Griffiths, G H Nabozny, J Hanson, et al.Pageof 189